Nvidia, QIA-backed Iambic Therapeutics files for US IPO as biotech boom rolls on
- Advertisement -
Most Popular
Commentary: Jollibee shouldn’t rush its global IPO
The fast-food powerhouse from the Philippines has effectively become two businesses, says Juliana Liu for Bloomberg Opinion.
